Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

381 evidence items · page 10 / 16

1.3 risk_ratioLow breast cancer knowledge was associated with a risk ratio of 1.3 for advanced-stage diagnosis after early breast cancer detection.

Nigeriacancer du seinpublished 2021PloS onePubMeddocument of 6 observations

Albumin/CRP ratio was significantly associated with Subjective Global Assessment (SGA) categories in breast cancer patients (p = 0.002).

Nigeriacancer du seinobserved January and June 2018published 2022Nutrition and cancerPubMeddocument of 7 observations

40.3 per_1The male-to-female ratio among breast cancer cases was 40.3:1.

Nigeriacancer du seinpublished 2024West African journal of medicinePubMeddocument of 13 observations

All breast cancer patients with pathogenic BRCA1/2 variants had triple-negative breast cancer (TNBC) and a family history of cancer.

Nigeriacancer du sein · triple-negative breast cancer (TNBC)published 2025Technology in cancer research & treatmentPubMeddocument of 2 observations

23.6 %The proportion of metastatic breast cancer cases was 23.6% during 2013–2015.

Nigeriacancer du seinobserved 2013-2015published 2023West African journal of medicinePubMeddocument of 8 observations

30.4 %Lack of knowledge was reported as a barrier to breast cancer screening by 30.4% of participants.

Nigeriacancer du seinpublished 2023African health sciencesPubMeddocument of 4 observations

65.4 %The majority (65.4%) of the breast cancer patients were premenopausal.

Nigeriacancer du seinobserved 2011–2015published 2020The Pan African medical journalPubMeddocument of 16 observations

0.4 %Among all cases, 0.4% carried a loss-of-function mutation in TP53.

Nigeriacancer du seinpublished 2018Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument of 14 observations

41.8 %Among 294 Nigerian women with breast cancer who had immunohistochemical analysis, 41.8% were classified as triple-negative breast cancer (TNBC).

Nigeriacancer du seinpublished 2022Cancer epidemiologyPubMeddocument of 9 observations

33.3 %Breast cancer accounted for about a third of cases of pathological nipple discharge.

Nigeriacancer du sein · pathological nipple dischargepublished 2023West African journal of medicinePubMeddocument of 10 observations

49.8 yearsAmong 607 patients diagnosed with breast cancer in Nigeria between January 2010 and December 2018, 597 were female, with a mean age of 49.8 ± 12.2 years.

Nigeriacancer du seinobserved 2010–2018published 2021International journal of cancerPubMeddocument of 12 observations

50 %The overall five-year survival for breast cancer patients was 50%.

Nigeriacancer du seinpublished 2019The Pan African medical journalPubMeddocument of 7 observations

In Nigeria, access to mammography within 120 minutes ranges from 64.8% to 80.6% between northern and southern regions.

Nigeriacancer du seinpublished 2023JCO global oncologyPubMeddocument of 7 observations

52 monthsThe median survival for breast cancer patients was 52 months.

Nigeriacancer du seinpublished 2019The Pan African medical journalPubMeddocument of 7 observations

72 %72% of the tumors were node positive.

Nigeriacancer du seinpublished 2009Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument of 12 observationsDOI 10.1200/jco.2008.19.6873

31 %The hazard of progressing from early to locally advanced breast cancer was 31% in 90 days.

Nigeriacancer du seinobserved June 2017 to May 2018published 2020BMC public healthPubMeddocument of 9 observations

65.11 %Breast self-examination awareness was 65.11% among female students and staff of six educational institutions in Ota, Southwest Nigeria.

Nigeriacancer du seinpublished 2023African journal of reproductive healthPubMeddocument of 10 observations

40 daysThe median diagnostic interval was 40 days among young adult females with breast cancer in Nigeria.

Nigeriacancer du seinpublished 2025BMC cancerPubMeddocument of 11 observations

2,049 USDThe mean cost of diagnosis and treatment was $2,049 (SD $1,854).

Nigeriacancer du seinpublished 2022The Pan African medical journalPubMeddocument of 9 observations

70.8 %70.8% of breast cancer patients received systemic chemotherapy.

Nigeriacancer du seinobserved May 2009–January 2019published 2021CancerPubMeddocument of 7 observations

3.7 %Among cases, 3.7% (37 individuals) were classified as high risk using a lifetime absolute risk threshold of 10% or higher in the epidemiologic factors only model.

Nigeriacancer du seinpublished 2025JAMA network openPubMeddocument of 6 observations

0.21 odds_ratioWomen in the highest category of educational attainment had an odds ratio of 0.21 for breast cancer compared to those in the lowest category after adjustments.

Nigeriacancer du seinpublished 2022The Pan African medical journalPubMeddocument of 5 observations

13.7 %13.70% of participants lacked knowledge about the effects of carbonated drink consumption on breast cancer risk.

Nigeriacancer du seinpublished 2024JCO global oncologyPubMeddocument of 12 observations

76 %Among breast cancer cases recorded by the Edo-Benin Cancer Registry (EBCR) from 2016 to 2018, 76% of those detected via health check-ups were assigned to palliative care compared to 58% of those detected clinically.

Nigeriacancer du seinobserved 2016 to 2018published 2025Cancer causes & control : CCCPubMeddocument of 9 observations

0.21 correlation_coefficientTNF-α correlated with tumor-infiltrating lymphocytes (TILs) (ρ = 0.21; p = 0.026).

Nigeriacancer du seinpublished 2026Breast cancer research and treatmentPubMeddocument of 14 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.